Zhou et al.’s comprehensive review emphasized the pivotal role of WT KRAS in influencing both tumor progression and regression in cancers harboring mutant KRAS, highlighting its context-dependent effects on disease trajectory and therapeutic response [27]. The gene discussed is KRAS; the disease is neoplasm.